NCT07210398

Brief Summary

The goal of this clinical trial is to pilot an adaptation of mindfulness-based cognitive therapy for chronic pain and early cognitive decline. The main questions it aims to answer in a later fully powered randomized controlled trial are:

  • Is an adaptation of mindfulness-based cognitive therapy for older Black adults able to improve quality of life?
  • Will an adapted mindfulness based cognitive therapy reduce pain interference to a greater degree than a traditional health enhancement program?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for not_applicable chronic-pain

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable chronic-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 5, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 22, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 22, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 29, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 7, 2025

Completed
6 months until next milestone

Results Posted

Study results publicly available

April 17, 2026

Completed
Last Updated

April 17, 2026

Status Verified

February 1, 2026

Enrollment Period

8 months

First QC Date

September 29, 2025

Results QC Date

January 20, 2026

Last Update Submit

April 3, 2026

Conditions

Keywords

mindfulness-based cognitive therapymind-bodychronic painearly cognitive declineolder adult

Outcome Measures

Primary Outcomes (3)

  • The Credibility and Expectancy Questionnaire

    The Credibility/Expectancy Questionnaire (CEQ) is a 6-item self-report measure assessing treatment credibility (items 1-3) and expectancy (items 4-6). Items 1-3 and 5 are rated 0 (not at all credible/logical) to 9 (extremely credible/logical), while items 4 and 6 are rated 0% to 100%; subscale scores are standardized and summed (credibility: 3-27 raw equivalent; expectancy similar), with total scores ranging 6-54 after standardization, where higher scores indicate greater credibility and positive outcome expectancy (better outcome).

    At enrollment

  • The Client Satisfaction Questionnaire

    The 3-item version of the Client Satisfaction Questionnaire (CSQ-3) is scored by summing responses from its three core items. It consists of empirically selected items measuring key aspects of service satisfaction, each rated on a 4-point Likert scale (1 = lowest satisfaction to 4 = highest, with directionality adjusted as needed). Total scores range from 3 to 12, with higher values indicating greater satisfaction; no reverse scoring or subscales are required.

    Administered at the end of treatment at 8 weeks.

  • Modified Patient Global Impression of Change

    The Modified Patient Global Impression of Change (mPGIC) adapts the standard single-item Patient Global Impression of Change (PGIC), a validated patient-reported outcome measure of overall perceived change since intervention, by assessing change across six specific domains. Each domain uses a single ordinal item rated on a 6-point scale: Very Much Improved (coded 5), Much Improved (4), Minimally Improved (3), No Change (2), Minimally Worse (1), or Much Worse (0). The range per domain is 0 (worst, Much Worse) to 5 (best, Very Much Improved), with higher scores indicating greater perceived improvement. Domains are analyzed individually as mean scores (no total computed), where values \>2.5 reflect net positive change. Domains include coping strategies, physical activity, social activity, level of stress, memory and thinking, and pain.

    At end of 8 week program (post test) and again at 3 month follow up visit.

Secondary Outcomes (13)

  • Numerical Rating Scale

    From enrollment to 3 months from the end of treatment at 8 weeks.

  • PROMIS Physical Function

    From enrollment to 3 months from the end of treatment at 8 weeks.

  • PROMIS Anxiety

    From enrollment to 3 months from the end of treatment at 8 weeks

  • PROMIS Emotional Support

    From enrollment to 3 months from the end of treatment at 8 weeks

  • Measure of Current Status Part A

    From enrollment to 3 months from the end of treatment at 8 weeks.

  • +8 more secondary outcomes

Study Arms (1)

Mindfulness-based cognitive therapy

EXPERIMENTAL
Behavioral: Mindfulness-based cognitive therapy

Interventions

The delivered intervention is mindfulness-based cognitive therapy adapted for the chronic pain and cognitive decline comorbidity among older Black adults. Mindfulness-based cognitive therapy (MBCT) is a structured psychotherapy that integrates mindfulness practices with cognitive behavioral therapy techniques. This adapted MBCT is delivered as an 8-week group-based program with each weekly session lasting about 1 hour. Sessions occur once per week, supplemented by daily home practice of 40-60 minutes, 6 days a week, involving guided meditations, body scans, and mindful activities to reinforce skills.

Mindfulness-based cognitive therapy

Eligibility Criteria

Age50 Years - 120 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Older adult (age ≥ 50)
  • All individuals who identify with one or more nationalities or ethnic groups originating in any of the Black racial groups of Africa
  • Pain in muscles, joints, bones, or associated soft tissues (NRS\>4) lasting longer than 3 months
  • Early Cognitive Decline (subjective or MCI)
  • Telephone Interview for Cognitive Status-41 score ≥ 26
  • Functional Activities Questionnaire score \< 9
  • English fluency/literacy
  • Ability and willingness to participate via in-person and video
  • Willing to provide informed consent and comply with all aspects of the protocol

You may not qualify if:

  • Current substance abuse/dependence
  • Significant cognitive impairment
  • History of more than 8 sessions of cognitive-behavioral therapy
  • History of previous training in mindfulness or undergoing counseling more than once a month
  • History of or current diagnosis of psychosis
  • Active suicidal ideation or self-harm within the past 90 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

MeSH Terms

Conditions

Chronic PainCognitive Dysfunction

Interventions

Mindfulness-Based Cognitive Therapy

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsCognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Results Point of Contact

Title
Tony V Pham
Organization
Massachusetts General Hospital/Harvard Medical School

Study Officials

  • Tony V Pham

    MGH

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator and Psychiatrist

Study Record Dates

First Submitted

September 29, 2025

First Posted

October 7, 2025

Study Start

December 5, 2024

Primary Completion

July 22, 2025

Study Completion

July 22, 2025

Last Updated

April 17, 2026

Results First Posted

April 17, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

All IPD collected throughout the trial.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE

Locations